| DICOM PS3.3 2020d - Information Object Definitions |
|---|
Table C.26-1 specifies the Attributes used to convey the characteristics or parameters of a contrast agent, drug, or device.
Table C.26-1. Product Characteristics Module Attributes
|
Identifier of the contrast agent, drug, or device being characterized, typically from a package bar code, RFID, or other materials management ID. This ID might not be globally unique and might conflict with other IDs used within the scope of the institution. |
||
|
For drugs, a coded terminology in the US is RxNorm For devices, a coded terminology in the US is the FDA CDRH Product Code Classification |
||
|
Further description in free form text describing the drug or device. |
||
|
Identifier of the manufacturing batch of which this product is part. |
||
|
The date and time after which the manufacturer no longer ensures the safety, quality, and/or proper functioning of the material. |
||
|
>Include Table 10-2 “Content Item Macro Attributes Description” |
For drugs or contrast agents, for Concept Name Code Sequence, BCID 4050 “Drug or Contrast Agent Characteristics” For devices, for Concept Name Code Sequence, BCID 3423 “Numeric Device Characteristics” |
|
|
Unique identifier for the class of an HL7 Structured Product Label document. |
||
|
Unique identifier for the HL7 Structured Product Label Document as used in DICOM Instance references (see Section C.12.1.1.6) |
||
|
Instance Identifier of the referenced HL7 Structured Document, encoded as a UID (OID or UUID), concatenated with a caret ("^") and Extension value (if Extension is present in Instance Identifier). |
||
|
Retrieval access path to Product Label Document. Includes fully specified scheme, authority, path, and query in accordance with [RFC3986] |
||
| DICOM PS3.3 2020d - Information Object Definitions |
|---|